Bioavailability Study Design: Healthy Subjects Versus Patients
Analysis of Population Pharmacokinetic Data
Bioavailability: Influencing Factors
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Bioavailability Study Design: Single Versus Multiple Dose Studies
Therapeutic Drug Monitoring: Drug Analysis Methods
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 19, 2026

Microsampling in Targeted Mass Spectrometry-Based Protein Analysis of Low-Abundance Proteins
Published on: January 13, 2023
Peter van Amsterdam1, Margarete Brudny-Kloeppel
1Department of Clinical Pharmacology & Bioanalytics, Abbott Healthcare Products, CJ van Houtenlaan 36, Weesp, The Netherlands.
No abstract available in PubMed .